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Mason–Pfizer monkey virus (M-PMV) Gag protein contains a domain p12 that is unique to this virus (simian retrovirus-3) and its close
relatives. The α-helical N-terminal half of p12, which contains a leucine zipper-like region, forms ordered structures in E. coli and the C-terminal
half can form SDS-resistant oligomers in vitro. Together these properties suggest that p12 is a strong protein–protein interaction domain that
facilitates Gag–Gag oligomerization. We have analyzed the oligomerization potential of a panel of p12 mutants, including versions containing
substituted dimer, trimer, and tetramer leucine zippers, expressed in bacteria and in the context of the Gag precursor expressed in vitro and in cells.
Purified recombinant p12 and its mutants could form various oligomers as shown by chemical cross-linking experiments. Within Gag these same
mutants could assemble when overexpressed in cells. In contrast, all the mutants, including the leucine zipper mutants, were assembly defective in
a cell-free system. These data highlight the importance of a region containing alternating leucines and isoleucines within p12, but also indicate that
this domain's scaffold-like function is more complex than small number oligomerization.
© 2007 Elsevier Inc. All rights reserved.Keywords: M-PMV; p12 protein; Oligomerization; Leucine zipper; Retrovirus assemblyIntroduction
Most retroviruses form immature capsids at the plasma
membrane of the infected cell in an assembly process linked to
budding. In contrast, Mason–Pfizer monkey virus (M-PMV), as
a representative of the Betaretrovirus genus, forms its immature
capsids in the cytoplasm prior to transport to the plasma mem-
brane for envelopment and release (Rhee et al., 1990). The Gag
polyprotein precursor is the sole essential viral protein required
for the assembly of most retroviruses. Like all retrovirus Gag
proteins M-PMVGag contains a matrix (MA), capsid (CA), and
nucleocapsid (NC) domain. Thematrix (MA) domain ofM-PMV⁎ Corresponding authors. T. Ruml is to be contacted at Department of
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doi:10.1016/j.virol.2007.03.053Gag contains a cytoplasmic targeting/retention signal (CTRS)
that is responsible for the transport of Gag molecules to the
assembly site in the cytoplasm (Rhee and Hunter, 1990). The
CTRS can be inserted into MA of Moloney murine leukemia
virus (Mo-MLV) Gag to change the assembly phenotype of this
Gammaretrovirus from membrane-associated to Betaretrovirus-
like intracytoplasmic assembly (Choi et al., 1999). Later it was
reported that M-PMVMA is responsible for targeting of nascent
Gag molecules to the pericentriolar region where assembly takes
place (Sfakianos et al., 2003). Following assembly the
myristylated M-PMV MA (Rhee and Hunter, 1987) then
mediates transport of immature capsids on recycling endosomal
vesicles to the plasma membrane for envelopment and release
(Sfakianos and Hunter, 2003).
While the morphogenic pathway of M-PMV Gag has been
described, the molecular interactions within the Gag precursor
that lead to immature particle assembly have not been ade-
quately described for any retrovirus. The pleomorphic nature of
retrovirus particles has hindered efforts to derive a high reso-
lution structure for immature particles; although, cryoelectron
261Z. Knejzlík et al. / Virology 365 (2007) 260–270microscopy has provided a radial model for the arrangement of
Gag with the several domains forming concentric rings of
density (Yeager et al., 1998; Briggs et al., 2004; Wilk et al.,
2001). However, these models lack sufficient resolution to
reveal the specific interactions within and among the Gag
domains that determine that structure.We are left to deduce those
interactions from biochemical and structural analyses of the
separate mature domains and of Gag fragments.
The MA, CA, and NC domains of several retroviruses all
have been shown to possess intermolecular interactions that
could lead to particle assembly. The human immunodeficiency
virus type 1 (HIV-1) MA was reported to trimerize (Hill et al.,
1996) and it is hypothesized that Gag trimerization driven by the
MA domain is an intermediate step in normal virion assembly
(Morikawa et al., 1998). Similarly, theM-PMVMA structure, as
determined by NMR, can be modeled as a trimer (Conte et al.,
1997). In contrast to MA, the CA domain of HIV has been
observed to form dimers in solution (Gamble et al., 1997) or
dimer-linked hexamers in assembled tubes and core-like
structures in which the N-terminal domain of CA forms the
outer hexamer and the C-terminal dimerization domain links
each hexamer ring with six adjacent rings (Li et al., 2000). A
recent analysis of membrane-bound myristylated HIV MA-CA
found a very similar arrangement of linked hexamers suggesting
the same arrangement of the N- and C-terminal domains of CA
(Alfadhli et al., 2005). Curiously, the same study found an
essentially identical hexamer arrangement of myristylated MA
bound to membrane rather than the trimer arrangement found in
crystals or in solution. The authors propose that MA's role is to
stack on top of the CA N-terminal domain thereby extending the
hexamer lattice up to the membrane and providing deep pockets
into which the cytoplasmic domains of the envelope protein
gp41 may insert. The NC domain is responsible for specific
packaging of retroviral genomic RNA (reviewed in D'Souza and
Summers, 2005). It also plays a critical role in virus assembly as
illustrated by the assembly of CA-NC proteins of Rous sarcoma
virus (RSV) and HIV into tubular virus-like particles (VLPs) by
addition of RNA (Campbell and Vogt, 1995; Gross et al., 1997).
Several studies of assembly of CA-NC have demonstrated that
substitution of the RNAwith DNA or even oligos could promote
assembly provided the minimal oligo length was sufficient to
induce dimerization of the protein (Campbell and Rein, 1999;
Ma and Vogt, 2002, 2004); although oligos were found to be
stimulating, but non-essential for the assembly of a similar M-
PMV ΔProCANC protein (Ulbrich et al., 2006). It has been
further demonstrated that VLP formation is still retained when
the NC domain is replaced with a dimer-promoting leucine
zipper, suggesting that Gag dimers are an important intermediate
in particle assembly (Accola et al., 2000; Johnson et al., 2002).
Taken all together these data can imply one of several models for
retrovirus assembly in which either dimers, trimers, or hexamers
form the intermediate precursor or fundamental building block
of the immature particle structure.
In addition to the three domains common to all retroviruses,
the M-PMV Gag polyprotein contains two additional major
protein domains: phosphoprotein pp24, and protein p12. Except
for the PPPYand PSAP late budding motifs (Yasuda and Hunter,1998, Gottwein et al., 2003) the function of pp24 is unknown.
However, the p12 domain has been demonstrated to facilitate
formation of immature particles in infected cells (Sommerfelt
et al., 1992). Yet the presence of the p12 domain is dispensable
for the formation of immature particles in high expression
systems (Sommerfelt et al., 1992; Sakalian and Hunter, 1999) or
for assembly in vitro with high concentrations of recombinant
Gag (Rumlova-Klikova et al., 2000). Analysis for assembly of
M-PMV Gag mutants with deletions within p12 has shown that
the portion comprising amino acids 1–25 of p12 is required for
efficient assembly (Sommerfelt et al., 1992; Sakalian and
Hunter, 1999). This functional region in p12 has been termed the
internal scaffold domain (ISD). The propensity of p12 to
facilitate assembly was further demonstrated by the ability of
chimeric HIV-1 Gag containing M-PMV p12 to assemble into
particles upon synthesis by in vitro translation (Sakalian et al.,
2002) while wild-type HIV-1 or RSV Gag do not assemble
(Sakalian et al., 1996). Conversely, a more recent study showed
that plasma membrane interaction, provided by the addition of
the src myristylation sequence, can restore particle production
forM-PMVGag containing an ISD deletion (Sakalian and Rapp,
2006). These results support a hypothesis in which the ISD and
cellular membranes provide an interchangeable scaffold-like
function in retrovirus assembly.
Previous analysis established the α-helical character of the
N-terminal half of p12 and its ability to oligomerize in vitro
(Knejzlik et al., 2004). The present manuscript describes a
functional analysis of specific amino acid residues within the
ISD required for oligomerization of p12 and for infectivity of the
virus. In addition, we hypothesized that, in a manner similar to
the studies where the NC domain can be replaced by a leucine
zipper, the α-helical leucine zipper-like ISD within p12 can be
substituted with leucine zippers with defined propensities to
form dimer, trimer, or tetramer oligomers. Such an analysis
could not only further elucidate the role of p12, but might also
reveal the preferred oligomeric state for the Gag intermediate
leading to assembly. We found that isolated p12 proteins
containing these leucine zipper substitutions could form the
expected dimer, trimer, and tetramer, while as previously
reported (Knejzlik et al., 2004) the wild-type formed predomi-
nantly higher ordered oligomers. However, none of the
substituted leucine zipper versions of p12 could functionally
substitute for the wild-type sequence in our most stringent test
for assembly in an in vitro translation system indicating that the
role of p12 in M-PMVassembly is more complex than that of a
simple protein–protein interaction domain.
Results
Oligomerization of wild-type and mutant p12
We have shown previously that M-PMV p12 can multimerize
in vitro (Knejzlik et al., 2004). However, the molecular
mechanism of this process remains unclear. CD spectra
indicating high helical content combined with the presence of
a short leucine heptad repeat (LZL motif, Fig. 1A) in the
N-terminal domain led to the hypothesis that this portion of p12
Fig. 1. (A) Primary structure of the α-helical p12 N-terminus (amino acids 1–43). Leucine residues within the LZL motif are shown in bold italics. Leucine and
isoleucine residues within the LILI motif are shown in bold underlined text. (B) Schematic representation of p12 mutants. Table at right indicates the context in which
individual mutants were analyzed.
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linking experiments (Knejzlik et al., 2004). However, the
presence of additional regularly spaced leucine and isoleucine
residues N-terminal to the LZL (LILI motif, Fig. 1A), but not in
register with it, left the specific mechanism of interaction
ambiguous. We sought to determine the relative contributions of
the LZL and LILI motifs to oligomerization of p12. Previously, it
had been shown that M-PMV Gag deletion mutant Δ26–54,
which is deleted of the LZL, but retains the LILI motif, forms
immature capsids in the in vitro rabbit reticulocyte translation
system (Sakalian and Hunter, 1999). To investigate the
contribution of the LILI and LZL motifs to the assembly of
immature particles we prepared p12 expression constructs with
these regions deleted. The LILI motif was also mutated by the
replacement of the leucine and isoleucine residues with alanines
(mutant LILI.A, Fig. 1B). In addition, to try to gain an
understanding of the stoichiometry of the initial interactions
leading to immature particle assembly, the entire LILI and LZL
regions were replaced by short α-helical regions derived from
the dimerization domain of transcription factor GCN4 (Fig. 1B).
Three variants of the GCN4 leucine zipper that form
predominantly a dimer, trimer, or tetramer were used (Fig. 1B,
dim p12, tri p12, tet p12, respectively; Harbury et al., 1993).
The p12 mutants were expressed in Escherichia coli, purified
by metallo-affinity chromatography, and then cross-linked with
DTSSP (Fig. 2). Consistent with our previous observation,Fig. 2. Oligomerization of p12 mutant proteins. Proteins were expressed in bacteria a
cross-linked by DTSSP and analyzed by non-reducing SDS–PAGE. Concentrations o
with Coomassie brilliant blue.wild-type p12 formed dimers, trimers, and tetramers, but also a
significant amount of higher order oligomers. Some small
portion of remaining monomer was also observed. Precise
assignment of higher-order oligomers was difficult due to the
heterogeneous nature of the cross-linked products resulting in
smeared bands. Cross-linked mutant LILI.A p12 produced
predominantly monomeric, dimeric and trimeric forms, likely
through the activity of the remaining LZL motif, but not the
higher order oligomers seen with the wild-type. The deletion of
the LZL motif in mutant Δ26–53 resulted predominantly in
formation of monomers and considerably lower amounts of
dimers and trimers. Additional N-terminal deletionsΔ5–25 and
Δ5–37 further diminished the multimerization capacity with
only a faint band corresponding to a dimer seen. Analysis of the
cross-linked GCN4 mutants showed the expected oligomer
species as the predominant product with dimer, trimer, and
tetramer produced, respectively. Consistent with our previous
crosslinking analysis (Knejzlik et al., 2004) these results
suggest that the N-terminal rather than the C-terminal half of
p12 contains most of the potential for oligomerization.
Gag proteins containing p12 mutations are competent for
particle assembly in transfected COS-1 cells
We next asked if mutant versions of p12, when expressed in
the context of Gag, could produce particles in cultured cells.nd purified by metalloafinity chromatography. Purified proteins (1 mg/ml) were
f DTSSP used in reactions are indicated at the top of each lane. Gels were stained
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the proviral genome of M-PMV (Fig. 1B). COS-1 cells were
transiently transfected with these constructs and the ability of the
Gag proteins to assemble intracellular immature capsids was
determined. All the expected intracellular polyprotein precursors
(i.e. Gag Pr78, Gag–Pro Pr95, Gag–Pro–Pol Pr180) were
observed after a 20-min pulse for all the M-PMV mutants tested
and all these versions of Gag were found to varying degrees in
the high-speed pellet indicating assembly (Fig. 3). However,
after the 2-h chase only about half of the deletion or LILI.A
mutant Gags were found in the pellet. In contrast, for wild-type
and all the GCN4 derived variants, Gag was found predomi-
nantly in the pellet after 2 h, suggesting that these versions
assembled more efficiently than the deletion and LILI.A
mutants.
To determine if the pelleted material was indeed in the form
of immature particles, transfected COS-1 cells were examined
by thin section electron microscopy. Wild-type M-PMVand all
its mutants were able to form intracellular immature particles in
these cells (Fig. 4A). To better observe the morphology of these
structures we also isolated intracellular particles for examination
by negative stain. Material consisting of similarly sized spheres
with shells of approximately the same apparent curvature and
thickness were obtained for all the mutants (Fig. 4B).
The ability of all the Gag mutants to produce intracellular
particles suggested that they should also produce budded
particles. To examine this directly, transfected COS-1 cells wereFig. 3. Pulse-chase of p12 mutant Gag proteins in COS-1 cells. COS-1 cells transfecte
were lysed at 0 h (pulse) and 2 h (chase). Cleared lysates were ultracentrifuged and Ga
immunoprecipitated with polyclonal anti-CA serum. Immunoprecipitates were ana
Gag-related proteins as defined in the key.pulse labeled and then Gag-related proteins in cell lysates and
culture supernatants were immunoprecipitated after 0-, 1-, 3-,
and 9-h chase times (Fig. 5A). Again, all the expected intra-
cellular polyprotein precursors were observed after the pulse for
all the M-PMV mutants tested. The presence of the matured CA
protein p27 in the medium of most transfected cells is evidence
for activation of the viral proteinase during budding and thus of
released particles. In the case of wild-type M-PMV an increase
in CA in the medium was observed with a corresponding
decrease of intracellular Gag, indicating efficient release and
maturation of M-PMV particles. Mutants Δ5–37, dim M-PMV,
trim M-PMV, and tet M-PMV all behaved similarly, but less
efficiently, than the wild-type. For mutant LILI.A particle
release appeared to be delayed with only a modest amount of
CA seen in the medium at 9 h. For mutant Δp12 the kinetics of
release were also similar to most of the mutants, but the profile
of protein bands did not match that of the expected CA, as seen
for the others. To confirm that these bands are Gag-related,
Western blot analysis was performed on isolated particles
released into the medium from unlabeled transfected cells. All
the mutant particles tested, except those derived from the Δp12
M-PMV, contained CA protein of the expected molecular size.
However, the majority of CA from Δp12 M-PMV was cleaved
or found in higher molecular weight bands (Fig. 5B). This is
likely due to the loss of the natural cleavage sites and the
creation of an inefficiently processed hybrid cleavage site by
removal of the entire p12 domain. Previous analysis of thisd with mutant proviral constructs were radiolabeled with [35S]-methionine. Cells
g-related proteins from the pellet (P), supernatant (S), and from the medium were
lysed by SDS–PAGE followed by autoradiography. Arrows indicate the four
Fig. 4. EM analysis of immature particles. COS-1 cells were transiently transfected with individual proviral constructs and (A) intracellular particles were viewed by
thin section or (B) isolated particles were viewed by negative stain. White arrowheads point to immature particles. Images were taken at 75,000× magnification.
264 Z. Knejzlík et al. / Virology 365 (2007) 260–270mutant showed a similar altered processing of Gag; however,
only a single larger 45-kDa product was observed (Δ1–83,
Sommerfelt et al., 1992).
Mutations in p12 impair the assembly of M-PMV Gag in a
cell-free system
All the tested mutants could assemble into particles when
expressed in COS-1 cells where expression levels are artificially
high. We therefore reexamined these mutants in an in vitro
assembly system. This system is based upon in vitro translation
in a rabbit reticulocyte lysate where following protein synthesis,
the formation of assembled immature particle-like structures can
be examined by sucrose gradient centrifugation (Sakalian et al.,
1996). A previous analysis of p12 deletion mutants showed that
this system can faithfully reproduce the assembly phenotypesseen by expression in HeLa cells (Sommerfelt et al., 1992) where
deletion mutants Δ26–53 and Δ54–83 were competent for
assembly, but mutantsΔ1–25 andΔ1–83 (herein termedΔp12)
were completely defective (Sakalian and Hunter, 1999). In
contrast, overexpression of Δ1–25 or Δp12 in COS-1 cells
(Sommerfelt et al., 1992) or in bacteria (Sakalian and Hunter,
1999) yielded morphologically normal particles.
Mutants dim p12, tri p12, and tet p12, as well as LILI.A and
Δ5–37, were subcloned into the in vitro Gag expression vector
for analysis. Wild-type and mutantΔp12 were also examined in
parallel. As for the previously examined Δ1–25 and Δp12, all
the new Gag mutants examined in the in vitro system were
defective for assembly (Fig. 6). Wild-type Gag was detected
predominantly in fractions where assembled immature Gag
particles would be expected to sediment (Sakalian et al., 1996).
However, all the mutant versions of Gag were present in
Fig. 5. (A) Analysis of viral particles released from COS-1 cells. COS-1 cells transfected with mutant proviral constructs were pulse radiolabeled with [35S]-methionine
and chased for 1, 3, or 9 h. Gag related proteins from cell lysates and viral pellets were immunoprecipitated in the presence of 0.1% SDS. Immunoprecipitates were
analysed by SDS–PAGE followed by autoradiography. (B) Western blot analysis of released particles. Particles were isolated from media 48 h after transfection and
analyzed by immunoblotting using antibody against CA.
265Z. Knejzlík et al. / Virology 365 (2007) 260–270fractions of significantly lower density indicating an impaired
ability to form particles. These steep gradients (25–55% w/w
sucrose) provide insufficient resolution to determine if the
material in the lighter fractions is only monomer Gag. Thus, the
production of small oligomer assembly intermediates cannot be
excluded. These results demonstrate that the p12 LZL region,
retained in mutant LILI.A, or the GCN4-derived leucine zippers
are not sufficient for assembly in vitro. The results also highlight
the critical importance of the LILI motif for efficient assembly.
In contrast to all the other mutants containing significant
deletions or substitutions, mutant LILI.A contained only four
residue changes, yet it was also completely defective.
Leucine-zipper substituted p12 mutant particles are
noninfectious
Although previous analysis of p12 deletion mutant particles
found them to be non-infectious (Sommerfelt et al., 1992), we
have created new mutants with leucine zipper substitutions
rather than deletions. To test their infectivity M-PMV mutant
particles released from transfected COS-1 cells were collected
2 days post transfection, the amounts normalized to wild-type,
and used for infection of human osteosarcoma (HOS) cells.
Infectivity was monitored by immunoblot assay for CA in the
culture medium at 4-day intervals (Fig. 7). In contrast to thewild-type no CA was detected in the cultures infected with the
Δp12, tri and tet M-PMV mutants (not shown). Interestingly,
measurable, albeit significantly lower amounts of CA were
found in the cultures infected with Δ5–37 M-PMV and dim
M-PMV, and the amount of particles produced by these two
mutants did not significantly increase over time.
Discussion
Our results point to the importance of p12 multimerization
for immature particle assembly. The role of the N-terminal half
of p12 was specifically underscored by the fact that substituted
GCN4 leucine zippers cannot replace the function of this region
in the in vitro low expression system. We had hypothesized that
one of the leucine zipper forms would be preferred for assembly
and therefore point toward the initial stoichiometry of Gag
association that leads to assembly. Recent studies of assembled
fragments of Gag by negative stain and freeze fracture electron
microscopy have indicated that M-PMV immature capsids may
assemble from trimers, although this conclusion is yet to be
supported by biochemical evidence (Nermut et al., 2002). Why
then didn't the substitution mutant versions of Gag assemble in
vitro? One must conclude that simple trimerization, or even di-
or tetramerization, is insufficient to replace p12 function. The
LILI.A mutant, which contains the substitution of the leucines
Fig. 6. Assembly of M-PMV Gag mutants in a cell-free system. Individual Gag
mutants were translated in rabbit reticulocyte lysates in the presence of
[35S]-methionine. Reactions were then analysed by ultracentrifugation in linear
25–55% (w/w) sucrose gradients followed by SDS–PAGE of the gradient
fractions. (A) Portions of autoradiograms showing the Gag protein band for wild
type and each mutant. (B) Quantification of band intensity.
Fig. 7. Infectivity of wild-type and mutant M-PMV. HOS cells were infected by
viral particles obtained from transfected COS-1 cells. The infection was
monitored by assay of CA in the culture medium at 4-day intervals. Inset shows
the greatly reduced extent of infection for two of the mutants.
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motif, is instructive in this regard in that this mutant in cross-
linking experiments could form all three permutations of
oligos in solution – dimer, trimer, and tetramer – yet it too was
assembly defective in the context of Gag in vitro. In contrast,
wild-type p12 in solution formed predominantly higher order
oligomers, which could not be resolved in our gels. Since only
the four leucines or isoleucines were substituted in LILI.A, we
are led to the conclusion that hydrophobic residues in this
region promote a necessarily more complex Gag–Gag
interaction than simple small number oligo formation.
While the three substituted forms of the GCN4 leucine zipper
were all equally defective for assembly in vitro, they were all
equally tolerated for assembly in cells. This apparently contra-
dictory data is consistent with previous results where expression
of Gag at unnatural levels could overcome an assembly defect
seen when levels mirror those in an infected cell. Vaccinia/T7 or
COS cell overexpression, or expression in bacteria, of several
p12 deletion mutants yielded assembled particles, while
expression of those same mutants in HeLa cells or in vitro did
not (Sommerfelt et al., 1992; Sakalian and Hunter, 1999). The
conditional requirement for p12 is what led to the designation of
its functional region as an internal scaffold. This behavior
mimics the activity of the scaffold proteins of numerous phage,
which are not required for assembly if the core protein is present
in sufficient quantity, but which increase the efficiency and
fidelity of assembly when core protein concentration is low. The
ability to assemble in the absence of p12 when M-PMV Gag isin sufficient quantity reaffirms the primary roles in assembly for
the remaining several domains of Gag. At a minimum, the CA
domain in this context must be competent to drive the assembly
of spherical particles (Fig. 4). It is also likely that the MA
domain contributes to this process by providing the CTRS and
thus the further concentrating effect of cellular transport.
We hypothesize that p12, primarily through the action of the
LILI motif, enhances the association of Gag molecules, thereby
increasing the efficiency of immature particle assembly. An
apparent contradiction in our results is the poor oligomerization
potential of mutant Δ26–53 in solution (Fig. 2). Although this
mutant lacks the LZL motif, it retains the LILI motif and as
shown in our previous report, is competent to assemble in the in
vitro system (Sakalian and Hunter, 1999). Thus, the main
driving force for oligomerization in the context of Gag appears
to be provided by the LILI motif. The ability of p12 and the
LILI motif to promote Gag–Gag interaction provides a
mechanistic explanation for the inducement of HIV-1 Gag
assembly in the in vitro rabbit reticulocyte lysate system by p12
insertion between MA and CA or fusion downstream of NC
(Sakalian et al., 2002).
M-PMV is a Betaretrovirus. The other prominent member of
this genus is mouse mammary tumor virus (MMTV). Since
MMTV assembles by a similar morphogenic pathway, one
might expect a similar p12-like ISD to be present within its Gag
polyprotein. While a similar acidic residue-rich region lies in the
analogous position within MMTV Gag (Sommerfelt et al.,
1992), it does not possess the strong protein–protein interaction
potential of p12. Instead this potential is apparently spread over
the multiple domains of the polyprotein (Zabransky et al.,
2005). Both M-PMV and MMTV do contain the CTRS (Rhee
and Hunter, 1990), but it appears that these two Betaretroviruses
have evolved different solutions to the particular challenge of
intracytoplasmic assembly. Why do Betaretrovirus Gags re-
quired this auxiliary assembly function? As we have proposed
previously, the multimerization behavior of the ISD appears to
267Z. Knejzlík et al. / Virology 365 (2007) 260–270fill the same role in assembly as the membrane for other retro-
viruses (Sakalian and Rapp, 2006). The beyond oligomerization
to multimerization capacity of p12 is consistent with this hypo-
thesis since membrane or even submembrane domain inter-
action, with the theoretical freedom of complexes to expand
outwardly in two dimensions, should be capable of facilitating
more than just small Gag oligomers.
Finally, we tested the infectivity of the leucine zipper sub-
stitution mutants when expressed in the context of a full
provirus. Consistent with a previous report that deletion mutants
in p12 would yield non-infectious particles when overexpressed,
we found that most mutants failed to produce replication
competent particles. However, two mutants, Δ5–37 M-PMV
and dim M-PMV, yielded a low level of replication. This is the
first report of any p12 mutant retaining infectivity. It remains to
be determined what specific role beyond assembly of Gag that
M-PMV p12 and its motifs play in infectivity and replication.
Materials and methods
Constructs
The plasmid pBlsΔGag was constructed as follows: The
SpeI–BamHI gag fragment containing the entire p12 domain
was subcloned from plasmid pTFCG.Bam(−) (Sakalian et al.,
2002) into the pBluescript IIKS+ vector (Stratagene). Next,
pBlsΔGag was used as a template for the replacement of codons
5–37 in the p12 sequence by 32-codon-long dimer, trimer or
tetramer leucine zipper motifs derived from the yeast transcrip-
tion factor GCN4 (Harbury et al., 1993). The plasmids carrying
the sequences encoding the individual GCN4-derived leucine
zippers were p4LZ for the dimer (Lumb et al., 1994) obtained
from Dr. Peter Kim (Massachusetts Institute of Technology),
pII41N for the trimer (Weissenhorn et al., 1997) obtained from
Dr. Don Wiley (Harvard University), and pAED4LZ.tet for the
tetramer, which is designed to express the tetrameric “LI”
peptide according to the studies of Harbury et al. (1993),
obtained from Dr. Andrea Cochran (Massachusetts Institute of
Technology). The dimer leucine zipper sequence was amplified
by PCR using primers 5′-GTAATGGCGGTTGTTAATC-
CAATGAAACAGCTGGAAGAC-3′ and 5′-CAGTTTCATT-
CCCTGTTTTTTCACCAACTAGTTTTTTCAGGCG-3′ con-
taining 5′ overhangs complementary to p12 sequences flanking
the substitution. The trimer leucine zipper was amplified using
primers 5′-GTAATGGCGGTTGTTAATCCAATGAAACA-
GATCGAAGAC-3′ and 5′-CAGTTTCATTCCCTGTTTTTT-
CACCGATCAGTTTTTTGATACG-3′. The tetramer leucine
zipper was amplified using primers 5′-GTAATGGCGGTT-
GTTAATCCACTGAAACAGATTGAAGAC-3′ and 5′-
CAGTTTCATTCCCTGTTTTTTCACCAACTAGTTT-
TTTAATGCG-3′. The resulting PCR products were then used as
megaprimers for PCR mutagenesis of pBlsΔGag. The regions
replaced in the p12 coding sequence within pBlsΔGag were
confirmed by sequencing and subsequently subcloned into
pTFCG.Bam(−) using restriction sites SpeI and NcoI. These
operations resulted in derivatives of pTFCG.Bam(−) carrying the
dimer, trimer and tetramer domains within p12 designated aspTFCG.Bam(−)dimp12, pTFCG.Bam(−)trip12 and pTFCG.
Bam(−)tetp12, respectively.
Amino acid substitutions and deletions within p12 were
constructed by PCRmutagenesis within the pBlsΔGag vector. A
construct where the leucines and isoleucines of the heptad repeat
motif LILI (Fig. 1) were mutated or deleted were designated as
pTFCG.Bam(−)LILI.Ap12 and pTFCG.Bam(−)Δ5–37p12,
respectively. For construction of pTFCG.Bam(−)LILI.Ap12
primer P 5′-GTAATGGCGGTTGTTAATCCAAAAACAGG-
GAATGAAACTG-3′ was used and for the construction of
pTFCG.Bam(−)Δ5–37p12 primer Z 5′-CAGTTTCATTC-
CCTGTTTTTGGATTAACAACCGCCATTAC-3′ was used.
These primers were used in combination with primer X 5′-
CCAAAAGAGGAGGCCAAAGAAAAAGCTGCTCAAG-
CAGAGGAACAGGCTAAATTAG AAGAG-3′ and primer Y
5′-CTCTTCTAATTTAGCCTGTTCCTCTGCTTGAG-
CAGCTTTTTCTTTGGCCTCCTCTTTTGG-3′ to perform
PCR mutagenesis. The desired sequences within pBlsΔGag
were confirmed by sequencing and then subcloned into pTFCG.
Bam(−) using SpeI and NcoI. To also examine the various p12
mutants in the context of a whole provirus these were subcloned
from the pBlsΔGag derivatives into plasmid pSHRM15, an
infectious molecular clone of M-PMV (Rhee et al., 1990).
pTFCG.Bam(−)Δp12 was constructed as follows: the SpeI–
NcoI Δp12Gag fragment from pTFCGΔ1–83 (Sakalian and
Hunter, 1999) was subcloned into pTFCG.Bam(−) using
restriction sites SpeI and NcoI. Construction of pSHRM15 and
pSHRM15Δp12 was described previously (Rhee et al., 1990;
Sommerfelt et al., 1992).
For expression of mutant zipper p12 proteins in bacteria,
plasmids pET15bΔPP.dimp12, pET15bΔPP.trip12 and
pET15bΔPP.tetp12 were constructed as follows: the megapri-
mers for dimp12, trip12 and tetp12 were used for PCR muta-
genesis of pET15bHis6xΔPP.p12 (Knejzlik et al., 2004) using
the same protocol as for the mutagenesis of pBlsΔGag. Sim-
ilarly, plasmids pET15bΔPP.LILI.Ap12 and pET15bΔPP.Δ5–
37p12 were constructed by PCR mutagenesis using pET15b-
His6xΔPP.p12 as a template and the primer pairs X and Y or P
and Z, respectively. The expression plasmids pET15bΔPP.-
Δ26–53p12 and pET15bΔPP.Δ5–25p12 were constructed by
PCR mutagenesis of pET15bHis6xΔPP.p12 using the following





Purification of recombinant proteins
Expression and purification of p12 and its mutants was
described previously (Knejzlik et al., 2004). Briefly, the His6-
tagged proteins were expressed in E. coli BL21(DE3) in 200 ml
LB medium. The cells were pelleted and lysed in 20 ml of lysis
buffer (100 mM NaCl, 10 mM imidazole, 50 mM Na2HPO4,
pH 8.0, 100 μg/ml lysozyme, 50 μg/ml RNase, and 50 μg/ml
DNase) 4 h post-induction. The lysate was then sonicated and
centrifuged for 30 min at 40,000×g. The resulting supernatant
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4 °C. After washing with 30 ml of phosphate–urea buffer
(150 mM NaCl, 50 mM Na2HPO4, 1.5 M urea, pH 8.0), the
resin was resuspended in 1 ml of M-PMV protease buffer
(900 mM NaCl, 100 mM Na2HPO4, pH 6.2). Recombinant
M-PMV protease (0.05 mg/ml) was used to release p12 from the
His6-tagged portion of the fusion protein bound to the resin.
Cleavage was performed overnight at room temperature. The
released protein was concentrated to approximately 0.75 mg/ml
on a Centricon plus column.
Protein concentration determination
10 μl of the protein sample was mixed with 200 μl of
bicinchonic acid containing 0.2 % (w/v) CuSO4 (Lovrien and
Matulis, 1995). The mixture was incubated at 55 °C and the
protein concentration was measured by spectrophotometry at
562 nm after 30 min. BSA and lysozyme were used as standards
over a concentration curve of 0.2–2 mg/ml.
Cross-linking experiments
Proteins were dialysed against 50 mM phosphate buffer
(pH 7.4) containing 100 mMNaCl. Reactions were performed at
a protein concentration of 0.5 mg/ml in the presence of 1.2 or
0.6 mM 3,3′-dithiobis[sulfosuccinimidylpropionate] (DTSSP)
for 1 h at 25 °C. Reactions were stopped by additon of an equal
volume of non-reducing SDS–PAGE sample buffer and prod-
ucts were analyzed by Tris–tricine SDS–10% PAGE (Schägger
and Jagow, 1987).
Analysis of viral particle release and immunoprecipitation
COS-1 cells were maintained in Dulbecco's modified
Eagle's medium (DMEM) supplemented with 10% fetal bovine
serum, 20 mM L-glutamine, 100 U/ml of penicillin G and
100 μg/ml streptomycin sulfate. Cells were transfected with
FuGene 6 reagent (Roche) according to the manufacturer's
instructions. Cells in 35 mm diameter dishes were pulse-labeled
for 20 min in DMEM minus methionine (Specialty Media)
supplemented with 50 μCi/ml of [35S]-methionine (Tran35S-
Label™, MP Biomedicals). The labeling medium was removed
and the cells were washed with 2 ml of DMEM containing 10 %
fetal bovine serum. The samples were incubated in the same
medium until their analysis. Following the chase period, labeled
cells were lysed in buffer containing 0.15MNaCl, 50 mMTris–
HCl (pH 7.5), 1% Triton X-100, and 1% deoxycholate (Lysis
Buffer). Cellular debris and nuclei were removed by centrifuga-
tion for 1 min at 15,000×g. The lysate was then adjusted to 0.1%
SDS and the M-PMV Gag species were precipitated by the
addition of polyclonal anti-Pr78 antiserum (Sakalian et al.,
1996) followed by formalin-fixed Staphylococcus aureus. For
analysis of released virus particles, tissue culture medium was
first filtered through a 0.45-μm filter. Particles were then
collected by centrifugation through a 25% w/v sucrose cushion
in 20 mM Tris–HCl, 150 mM NaCl, 1 mM EDTA, pH 7.4
(TNE) at 250,000×g for 40 min. Pelleted virions were dissolvedin lysis buffer plus 0.1% SDS and the Gag species immunopre-
cipitated as for cell lysates. Immunoprecipitates were examined
by separation on SDS–12% PAGE gels followed by phosphor-
imager analysis.
Analysis for assembly of immature particles in transfected cells
At 48 h post-transfection pulse-radiolabeled COS-1 cells in
35 mm dishes were lysed for 10 min in 1 ml of lysis buffer at
4 °C. The cell lysate was precleared by a 1-min centrifugation at
15,000×g. The cleared lysate was collected and then centrifuged
at 250,000×g through 25 % (w/w) sucrose in TNE for 40 min at
4 °C. Supernatant was removed and the pellet was resuspended
in lysis buffer containing 0.1% SDS. The M-PMV-related
proteins were immunoprecipitated and analyzed as above.
Thin section electron microscopy
At 24 h post-transfection COS-1 cells were fixed for 30 min
with 2.5% glutaraldehyde/1% paraformaldehyde in 0.1 M
sodium cacodylate buffer and scrapped off the plate. The
pelleted cells were secondarily fixed with 2% osmium tetraoxide
for 1 h and stained with 4% saturated uranyl acetate. After
dehydration in increasing acetone concentrations and embed-
ding, thin sections were made and examined with a Jeol JEM-
1010 electron microscope operated at an acceleration voltage of
80 kV.
Isolation and imaging of M-PMV immature capsids
The method, previously described (Parker et al., 2001), is
based on the resistance of retroviral immature capsids to mild
nonionic detergent conditions. At 48 h post-transfection COS-1
cells were washed with cold TBS and then lysed by incubating
for 30 min on ice in hypotonic lysis buffer (10 mM Tris, 1 mM
EDTA, 1% (v/v) Triton X-100). The cell lysate was clarified by
centrifugation at 3000×g and loaded onto a step gradient of 35%
to 75% (w/v) sucrose in 10 mM Tris buffer, pH 7.6, and
centrifuged for 6 h, at 4 °C, at 25,000 rpm in a Sorvall TH641
rotor. The 75% sucrose cushion, including the 35% interface,
was carefully removed from the centrifuge tube and dialysed
overnight at 4 °C in 10 mM Tris buffer pH 7.6 (molecular
weight cutoff of 14 kDa). The immature capsids were
concentrated by centrifugation at 22,000×g for 30 min at 4 °C
and resuspended in hypotonic lysis buffer plus 500 mM NaCl
and centrifuged again through a 5%–20% sucrose gradient for
30 min at 25,000 rpm (Sorvall TH641 rotor). After fractionation
aliquots of the gradient fractions were analyzed by immunoblot
and the peak fractions containing Gag were selected. The
pooled fractions were then dialyzed and centrifuged again and
the resulting immature M-PMV particles resuspended in 10 mM
Tris buffer, pH 7.6. Particle samples were applied drop-wise
onto glow-discharged carbon-coated copper grids. After 5 min
for particle adsorption the grid was washed twice with filtered
distilled water, stained with 4% sodium silicotungstate, pH 7.2,
and allowed to dry. The samples were then analyzed with a Jeol
JEM-1010 electron microscope.
269Z. Knejzlík et al. / Virology 365 (2007) 260–270In vitro analysis of immature capsid assembly
The wild-type M-PMV Gag and its mutants (dim-, tri-, tet-,
Δ5–37- and Δp12-Gag) were translated in vitro for 90 min in
50 μl reactions using the pTFCGBam(−) vector derivatives
and the TNT-coupled reticulocyte lysate system (Promega) in
the presence of [35S]methionine. The reaction mixture was
diluted to a total volume of 200 μl by addition of 25 % (w/w)
sucrose dissolved in buffer containing 20 mM Tris–HCl
(pH 8.0), 100 mM NaCl, 1 mM EDTA and 0.1 % Triton
X-100 (IVA Buffer). The diluted samples were loaded onto
2.2 ml 25–55% (w/w) linear sucrose gradients in IVA buffer
and were centrifuged in a TLS-55 rotor (Beckman) at
55,000 rpm for 2 h. 190 μl fractions were collected from the
top of the gradient and the pellet was resuspended in 190 μl
55% (w/w) sucrose in IVA buffer. 10 μl of each fraction was
analyzed by SDS–12% PAGE and radiolabeled protein bands
were visualized by autoradiography on a Storm 840 Phos-
phorimager and quantified by ImageQuant software (Mole-
cular Dynamics).
Infectivity assay
COS-1 cells in 60-mm dishes were transfected with
pSHRM15 or its derivates containing mutations in the p12-
coding region of gag. The cultivation medium containing
released particles was collected after 48 h of incubation and the
quantity of capsid protein was determined by Western blot by
comparing the intensity of the capsid band to a standard curve
constructed with recombinant CA protein. Human osteosar-
coma (HOS) cells in 60-mm dishes were infected with 4 ml of
medium containing the wild-type or mutant virus normalized to
20 ng/ml of CA protein. Following infection the released mature
particles were isolated every 4 days from the cultivation
medium and the cells were split 1:4. Progeny virus was
quantified by Western blot as above.
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